000			01713 a2200445 4500
005			20250517143002.0
264		0	_c20180327
008			201803s 0 0 eng d
022			_a1548-5609
024	7		_a10.1053/j.ackd.2016.11.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aKlinkhammer, Barbara M
245	0	0	_aTreatment of Renal Fibrosis-Turning Challenges into Opportunities. _h[electronic resource]
260			_bAdvances in chronic kidney disease _c03 2017
300			_a117-129 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntibodies, Neutralizing _xtherapeutic use
650	0	4	_aBiomarkers
650	0	4	_aConnective Tissue Growth Factor _xantagonists & inhibitors
650	0	4	_aElasticity Imaging Techniques
650	0	4	_aEndpoint Determination
650	0	4	_aExtracellular Matrix
650	0	4	_aFibrosis
650	0	4	_aGalectin 3 _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aKidney _xdiagnostic imaging
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aPolysaccharides _xtherapeutic use
650	0	4	_aPyridones _xtherapeutic use
650	0	4	_aRenal Insufficiency, Chronic _xdrug therapy
650	0	4	_aTransforming Growth Factor beta _xantagonists & inhibitors
700	1		_aGoldschmeding, Roel
700	1		_aFloege, Jürgen
700	1		_aBoor, Peter
773	0		_tAdvances in chronic kidney disease _gvol. 24 _gno. 2 _gp. 117-129
856	4	0	_uhttps://doi.org/10.1053/j.ackd.2016.11.002 _zAvailable from publisher's website
999			_c26959433 _d26959433